zoledronic acid has been researched along with Femoral Fractures in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (8.82) | 29.6817 |
2010's | 30 (88.24) | 24.3611 |
2020's | 1 (2.94) | 2.80 |
Authors | Studies |
---|---|
Jiang, XY; Li, XP; Wu, XB; Yang, MH; Zhang, P; Zhu, SW | 1 |
Baba, N; Iguchi, H; Kawabata, H; Kinowaki, K; Kizawa, R; Kondoh, C; Masuda, J; Miura, Y; Ozaki, Y; Sakamaki, K; Shigekawa, T; Takahashi, M; Takano, T; Tamura, N; Tanabe, Y; Umezu, T | 1 |
Amizuka, N; Cui, P; Li, M; Liu, H; Sun, J; Sun, Q | 1 |
Dai, K; Hao, Y; Li, G; Pei, J; Wang, L; Yuan, G; Zhang, L | 1 |
Ikeda, S; Kataoka, M; Tsubouchi, Y; Tsumura, H | 1 |
Baldock, PA; Kostenuik, PJ; Little, DG; McDonald, MM; Mikulec, K; Morse, A; Peacock, L | 1 |
Chatterjee, S | 1 |
Bosemark, P; Isaksson, H; Tägil, M | 1 |
Aono, M; Hayashi, K; Kazuki, K; Shintani, K | 1 |
Bhadada, SK; Bhansali, A; Dhiman, V; Mithal, A; Muthukrishnan, J; Sharma, DC; Sridhar, S | 1 |
Cantrill, LC; Little, DG; Mikulec, K; Murphy, CM; Peacock, L; Schindeler, A | 1 |
Hu, J; Li, Y; Shui, X; Zhang, L | 1 |
Fassier, F; Glorieux, FH; Montpetit, K; Ouellet, J; Palomo, T; Rauch, F; Sato, A | 1 |
Adler, RA; Bauer, DC; Camacho, PM; Clarke, BL; Clines, GA; Compston, JE; Drake, MT; Edwards, BJ; El-Hajj Fuleihan, G; Favus, MJ; Greenspan, SL; McKinney, R; Pignolo, RJ; Sellmeyer, DE | 1 |
Dai, K; Ge, S; Hao, Y; Lu, Y; Mao, Z; Wang, L; Wang, X | 1 |
Aoyama, Y; Morii, K; Nakamura, S; Okushin, H | 1 |
Bismuth, H; Brin, YS; Coughlin, R; Heler, Z; Kish, BJ; Nyska, M; Palmanovich, E; Rotman, P; Zehavi, T | 1 |
Ataoğlu, B; Berkay, AF; Eren, TK; Kaptan, AY; Yapar, AE | 1 |
Lampropoulou-Adamidou, K; Tournis, S; Triantafyllopoulos, IK | 1 |
Alm, JJ; Halkosaari, HJ; Heino, TJ; Välimäki, VV | 1 |
Isaksson, H; Mathavan, N; Tägil, M | 1 |
Grasko, JM; Herrmann, RP; Vasikaran, SD | 1 |
Bauer, DC; Black, DM; Boonen, S; Bucci-Rechtweg, C; Cauley, J; de Papp, A; Eastell, R; Genant, HK; Kelly, MP; Leung, PC; Palermo, L; Santora, A | 1 |
Shane, E | 1 |
Pozzi, S; Raje, N | 1 |
Kosmidis, C; Lyritis, GP; Stathopoulos, KD | 1 |
Doi, Y; Hara, K; Kataoka, M; Miyazaki, M; Tsumura, H; Yoshiiwa, T | 1 |
Fujii, A; Fukuuchi, A; Ishizuna, K; Mori, M; Nishi, T; Ota, D; Teraoka, M | 1 |
Carter, CJ; Emory, CL; Ward, WG; Wilson, SC | 1 |
Coburn, SP; Ericson, KL; Mumm, S; Sutton, RA; Whyte, MP | 1 |
Gupta, SK; Reddy, SV | 1 |
Evangelista, PT; Levine, SM | 1 |
Amanat, N; Bransford, R; Godfrey, CB; Little, DG; McDonald, M | 1 |
Amanat, N; Bilston, L; Godfrey, C; Little, D; McDonald, M | 1 |
5 review(s) available for zoledronic acid and Femoral Fractures
Article | Year |
---|---|
Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Female; Femoral Fractures; Humans; Incidence; Male; Middle Aged; Osteoporosis; Retrospective Studies; Risk Factors; Zoledronic Acid | 2019 |
Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Femoral Fractures; Humans; Imidazoles; Middle Aged; Neoplasm Staging; Prognosis; Zoledronic Acid | 2014 |
Predictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literature.
Topics: Absorptiometry, Photon; Adult; Aged; Alendronate; Diphosphonates; Female; Femoral Fractures; Humans; Imidazoles; India; Middle Aged; Osteoporosis; Prodromal Symptoms; Retrospective Studies; Zoledronic Acid | 2014 |
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
Topics: Advisory Committees; Age Factors; Diphosphonates; Female; Femoral Fractures; Humans; Imidazoles; Male; Osteoporosis; Risk Factors; Sex Factors; Spinal Fractures; Zoledronic Acid | 2016 |
Atypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literature.
Topics: Adult; beta-Thalassemia; Bone Density Conservation Agents; Diphosphonates; Femoral Fractures; Humans; Imidazoles; Male; Osteoporosis; Zoledronic Acid | 2016 |
29 other study(ies) available for zoledronic acid and Femoral Fractures
Article | Year |
---|---|
All-cause mortality risk in older patients with femoral neck fracture.
Topics: Aged; Aged, 80 and over; Female; Femoral Fractures; Femoral Neck Fractures; Femur Neck; Hip Fractures; Humans; Male; Prospective Studies; Risk Factors; Zoledronic Acid | 2022 |
Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
Topics: Adaptor Proteins, Signal Transducing; Alkaline Phosphatase; Animals; Bone Density Conservation Agents; Cell Communication; Connexin 43; Diphosphonates; Disease Models, Animal; Extracellular Matrix Proteins; Femoral Fractures; Fracture Healing; Glycoproteins; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Mice; Osteoblasts; Osteoclasts; Osteocytes; Osteogenesis; Signal Transduction; Tartrate-Resistant Acid Phosphatase; Time Factors; Zoledronic Acid | 2018 |
Dual modulation of bone formation and resorption with zoledronic acid-loaded biodegradable magnesium alloy implants improves osteoporotic fracture healing: An in vitro and in vivo study.
Topics: Absorbable Implants; Alloys; Animals; Biocompatible Materials; Bone Development; Bone Nails; Bone Resorption; Cell Differentiation; Cells, Cultured; Diphosphonates; Female; Femoral Fractures; Fracture Healing; Imidazoles; Magnesium; Mesenchymal Stem Cells; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Osteoporotic Fractures; Rats, Sprague-Dawley; Zoledronic Acid | 2018 |
Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model.
Topics: Animals; Bone Density Conservation Agents; Bony Callus; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Femoral Fractures; Fracture Healing; Male; Radiography; Rats, Sprague-Dawley; Teriparatide; Zoledronic Acid | 2018 |
Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity.
Topics: Animals; Bone Density Conservation Agents; Clodronic Acid; Collagenases; Diphosphonates; Femoral Fractures; Fracture Healing; Humans; Hydroxamic Acids; Imidazoles; Male; Matrix Metalloproteinase Inhibitors; Osteoclasts; Osteoprotegerin; Pyrazines; Rats; Rats, Wistar; Recombinant Proteins; Sulfonamides; Time Factors; Zoledronic Acid | 2013 |
Atypical femoral fractures associated with long-term bisphosphonate use.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Humans; Imidazoles; Radiography; Zoledronic Acid | 2013 |
Influence of systemic bisphosphonate treatment on mechanical properties of BMP-induced calluses in a rat fracture model: comparison of three-point bending and twisting test.
Topics: Animals; Biomechanical Phenomena; Bone Density Conservation Agents; Bone Morphogenetic Protein 7; Bony Callus; Diphosphonates; Femoral Fractures; Imidazoles; Male; Osteotomy; Rats; Rats, Sprague-Dawley; X-Ray Microtomography; Zoledronic Acid | 2014 |
PTH(1-34) Treatment Increases Bisphosphonate Turnover in Fracture Repair in Rats.
Topics: Animals; Carbon Isotopes; Diphosphonates; Femoral Fractures; Fracture Healing; Imidazoles; Isotope Labeling; Male; Pamidronate; Parathyroid Hormone; Rats; Rats, Wistar; Zoledronic Acid | 2015 |
Cancellous bone healing around strontium-doped hydroxyapatite in osteoporotic rats previously treated with zoledronic acid.
Topics: Animals; Cancellous Bone; Diphosphonates; Durapatite; Female; Femoral Fractures; Fracture Healing; Imidazoles; Osteoporosis; Rats; Rats, Sprague-Dawley; Strontium; Zoledronic Acid | 2016 |
Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
Topics: Absorptiometry, Photon; Adolescent; Anthropometry; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcium; Child; Child, Preschool; Collagen Type I; Collagen Type I, alpha 1 Chain; Densitometry; Diphosphonates; Female; Femoral Fractures; Follow-Up Studies; Fractures, Compression; Humans; Imidazoles; Infant; Infusions, Intravenous; Lumbar Vertebrae; Male; Mutation; Osteogenesis Imperfecta; Pamidronate; Scoliosis; Spinal Fusion; Tibial Fractures; Zoledronic Acid | 2015 |
Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing.
Topics: Animals; Biomechanical Phenomena; Bone Density Conservation Agents; Bone Remodeling; Bony Callus; Diphosphonates; Female; Femoral Fractures; Fracture Healing; Imaging, Three-Dimensional; Imidazoles; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; X-Ray Microtomography; Zoledronic Acid | 2015 |
Synergistic anti-tumor effects of zoledronic acid and radiotherapy against metastatic hepatocellular carcinoma.
Topics: Aged; alpha-Fetoproteins; Biomarkers; Bone Neoplasms; Carcinoma, Hepatocellular; Combined Modality Therapy; Diphosphonates; Femoral Fractures; Humans; Imidazoles; Liver Cirrhosis; Liver Neoplasms; Macrophages; Male; Osteoclasts; Protein Precursors; Prothrombin; Severity of Illness Index; Zoledronic Acid | 2015 |
Spontaneous Bilateral Femoral Fractures After High-Dose Zoledronic Acid.
Topics: Aged; Bone Density Conservation Agents; Diaphyses; Diphosphonates; Female; Femoral Fractures; Fractures, Spontaneous; Humans; Imidazoles; Osteoporosis, Postmenopausal; Zoledronic Acid | 2015 |
Atypical femoral fracture following zoledronic acid treatment.
Topics: Absorptiometry, Photon; Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Female; Femoral Fractures; Fracture Fixation; Humans; Ibandronic Acid; Imidazoles; Magnetic Resonance Imaging; Osteoporosis; Treatment Outcome; Withholding Treatment; Zoledronic Acid | 2016 |
Zoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cells.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diphosphonates; Disease Models, Animal; Female; Femoral Fractures; Imidazoles; Mesenchymal Stem Cells; Rats; X-Ray Microtomography; Zoledronic Acid | 2016 |
Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
Topics: Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 7; Diaphyses; Diphosphonates; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Female; Femoral Fractures; Fracture Healing; Fractures, Open; Imidazoles; Osteoporotic Fractures; Ovariectomy; Radiography; Rats, Sprague-Dawley; Stress, Mechanical; X-Ray Microtomography; Zoledronic Acid | 2017 |
Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
Topics: Bone Density Conservation Agents; Cross Infection; Diphosphonates; Escherichia coli Infections; Fatal Outcome; Femoral Fractures; Fractures, Spontaneous; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Osteopetrosis; Recurrence; Zoledronic Acid | 2009 |
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Topics: Alendronate; Bone Density Conservation Agents; Confidence Intervals; Diphosphonates; Female; Femoral Fractures; Hip Fractures; Humans; Imidazoles; Osteoporosis; Randomized Controlled Trials as Topic; Zoledronic Acid | 2010 |
Evolving data about subtrochanteric fractures and bisphosphonates.
Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Hip Fractures; Humans; Imidazoles; Osteoporosis; Zoledronic Acid | 2010 |
Bisphosphonates and atypical femoral fractures.
Topics: Alendronate; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Femoral Fractures; Hip Fractures; Humans; Imidazoles; Osteonecrosis; Risk Factors; Zoledronic Acid | 2010 |
Atypical fractures of the femur and ulna and complications of fracture healing in a 76-year-old woman with Sjögren's syndrome.
Topics: Aged; Antimetabolites, Antineoplastic; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Fracture Healing; Humans; Imidazoles; Methotrexate; Radiography; Ulna Fractures; Zoledronic Acid | 2011 |
Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model.
Topics: Anabolic Agents; Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Diphosphonates; Disease Models, Animal; Drug Therapy, Combination; Femoral Fractures; Humans; Imidazoles; Male; Palpation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta; X-Ray Microtomography; Zoledronic Acid | 2011 |
A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diaphyses; Diphosphonates; Female; Femoral Fractures; Humans; Imidazoles; Middle Aged; Time Factors; Zoledronic Acid | 2015 |
Femoral stress fractures associated with long-term bisphosphonate treatment.
Topics: Aged; Aged, 80 and over; Alendronate; Diphosphonates; Female; Femoral Fractures; Fractures, Stress; Humans; Imidazoles; Length of Stay; Male; Middle Aged; Radiography; Retrospective Studies; Zoledronic Acid | 2012 |
"Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia.
Topics: Alendronate; Diphosphonates; Female; Femoral Fractures; Humans; Hypophosphatasia; Imidazoles; Middle Aged; Zoledronic Acid | 2012 |
Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Diphosphonates; Femoral Fractures; Follow-Up Studies; Fracture Fixation, Intramedullary; Fracture Healing; Fractures, Spontaneous; Humans; Imidazoles; Male; Neoplasm Staging; Orchiectomy; Osteoporosis; Prostatectomy; Prostatic Neoplasms; Radiography; Risk Assessment; Zoledronic Acid | 2012 |
Atypical insufficiency type femoral stress fractures in patient on bisphosphonates.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Fractures; Fractures, Stress; Humans; Imidazoles; Osteoporosis; Zoledronic Acid | 2012 |
Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Regeneration; Bony Callus; Cell Count; Diphosphonates; Elasticity; Femoral Fractures; Femur; Fracture Healing; Histocytochemistry; Imidazoles; Male; Osteoclasts; Rats; Rats, Wistar; Stress, Mechanical; Transforming Growth Factor beta; Zoledronic Acid | 2005 |
Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Bony Callus; Calcification, Physiologic; Cell Count; Diaphyses; Diphosphonates; Femoral Fractures; Fracture Healing; Imidazoles; Male; Osteoclasts; Rats; Rats, Wistar; Tomography, X-Ray Computed; Torque; Zoledronic Acid | 2007 |